[Neurolytic blocks for cancer pain--still a useful therapeutic strategy]. / Nevrolytisk blokade hos kreftpasienter--fortsatt en nyttig behandling.
Tidsskr Nor Laegeforen
; 124(4): 481-3, 2004 Feb 19.
Article
en Nor
| MEDLINE
| ID: mdl-14983193
ABSTRACT
BACKGROUND:
Patients with advanced cancer may present complex sets of symptoms, of which pain is the most prevalent. In addition to systemic pharmacological therapy for pain management, neurolytic blocks are also effective in controlling cancer pain in selected patients.METHOD:
Various neurolytic blocks used in the treatment of cancer pain are reviewed.RESULTS:
Several studies have documented the efficacy of neurolytic blocks in reducing pain intensity and opioid consumption, although good prospective, randomized controlled trials are scarce. The narrow risk-benefit ratio associated with neurolysis techniques requires knowledge of the complications associated with the different neurolytic blocks in order to minimise undesirable effects.INTERPRETATION:
Interventional techniques continue to play an important role in the management of cancer pain. The quality of the neurolytic blocks improves when they are performed image-guided in collaboration with an interventional radiologist. These blocks should never be considered an isolated treatment, but as a component of a comprehensive therapeutic strategy.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Dolor Intratable
/
Depresores del Sistema Nervioso Central
/
Neoplasias
/
Bloqueo Nervioso
Tipo de estudio:
Clinical_trials
Límite:
Humans
Idioma:
Nor
Revista:
Tidsskr Nor Laegeforen
Año:
2004
Tipo del documento:
Article